Abstract
This group of primarily chronic diseases have blisters as their primary clinical feature. The site of action may be within the epidermis, at the epidermal-dermal junction or in the very uppermost dermis. In some instances, the disorders are congenital with abnormal structural proteins. In other instances, they are acquired and described as autoimmune because they feature antibodies against structural components of the epidermis and epidermal-dermal junction. Still other blistering diseases have other mechanisms, such as the porphyrias (Chap. 44), or are entirely mysterious as is the case for bullous disease of diabetes (Chap. 48).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliography
Basic Science Aspects
Aumailley M, Krieg T (1996) Laminins: a family of diverse multifunctional molecules of basement membranes. J Invest Dermatol 106:209–214
Christiano AM, Uitto J (1996) Molecular complexity of the cutaneous basement membrane zone. Exp Dermatol 5: 1–11
McGrath JA (1999) Hereditary diseases of the desmosomes. J Dermatol Sci 20:85–91
McGrath JA, McMillan JR, Shemanko CS et al. (1997) Mutations in the plakophilin 1 gene result in ectodermal dys-plasia/skin fragility syndrome. Nat Genet 17:240–244
Shimizu H (1998) New insights into the immunoultrastruc-tural organization of cutaneous basement membrane zone molecules. Exp Dermatol 7:303–313
Uitto J (1997) Clinical implications of basic research on heritable skin diseases. J Dermatol 24:690–700
Epidermolysis Bullosa
Anton-Lamprecht I, Schnyder UW (1984) Prenatal diagnosis of epidermolysis bullosa hereditaria: a review. Semin Dermatol 3:229–240
Bart BJ, Gorlin RJ, Anderson VE et al. (1966) Congenital localized absence of skin and associated abnormalities resembling epidermolysis bullosa. A new syndrome. Arch Derm 93:296–304
Bruckner-Tuderman L, Mitsuhashi Y, Schnyder UW et al. (1989) Anchoring fibrils and type VII collagen are absent from skin in severe recessive dystrophic epidermolysis bullosa. J Invest Dermatol 93:3–9
Cockayne EA (1947) Recurrent bullous eruption of the feet. Br J Dermatol 59:109–112
Cohen BA, Esterly NB, Nelson PF (1985) Congenital erosive and vesicular dermatosis healing with reticulated supple scarring; Arch Dermatol 121:361–367
Christiano AM, Bart BJ, Epstein EH Jr et al. (1996) Genetic basis of Bart’s syndrome: a glycine substitution mutation in type VII collagen gene. J Invest Dermatol 106:1340–1342
Christiano AM, Fine J-D, Uitto J (1997) Genetic basis of do-minantly inherited transient bullous dermolysis of the newborn: a splice site mutation in the type VII collagen gene. J Invest Dermatol 109:811–814
Dowling GB, Meara RH (1954) Epidermolysis bullosa resembling juvenile dermatitis herpetiformis. Br J Dermatol 66:139–143
El Shafie M, Stidham GL, Klippel CH et al. (1979) Pyloric atresia and epidermolysis bullosa letalis: a lethal combination in two premature newborn siblings. J Pediatr Surg 14:446–449
Fine J-D, Johnson L, Wright T (1989) Epidermolysis bullosa simplex superficialis. A new variant of epidermolysis bullosa characterized by subcorneal skin cleavage mimicking peeling skin syndrome. Arch Dermatol 125: 633–638
Fine J-D, Bauer EA, Briggaman RA et al. (1991) Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. J Am Acad Dermatol 24:119–135
Fischer T, Gedde-Dahl T (1979) Epidermolysis bullosa simplex and mottled skin pigmentation. Clin Genet 15: 228–238
Gedde-Dahl T (1971) Epidermolysis bullosa: a clinical genetic and epidemiological study. John Hopkins Press, Baltimore, pp 1–180
Haber RM, Wedad H, Ramsay CA et al. (1985) Cicatricial junctional epidermolysis bullosa. J Am Acad Dermatol 12:836–844
Hashimoto K, Schnyder UW, Anton-Lamprecht I (1976) Epidermolysis bullosa hereditaria with junctional blistering in an adult. Dermatológica 152:72–86
Hashimoto K, Matsumoto M, Iacobelli D (1985) Transient bullous dermolysis of the newborn. Arch Dermatol 121: 1429–1438
Hintner H, Wolff K (1982) Generalised atrophic benign epidermolysis bullosa. Arch Dermatol 118:37s -384
Hovnanian A, Christiano AM, Uitto J (1993) The molecular genetics of dystrophic epidermolysis bullosa. Arch Dermatol 129:1566–1570
Ishida-Yamamoto A, McGrath JA, Chapman SJ et al. (1991) Epidermolysis bullosa simplex (Dowling-Meara type) is a genetic disease characterized by an abnormal keratin-filament network involving keratins K5 and K14. J Invest Dermatol 97:959–968
Jonkman MF, Jong MCJM de, Heeres K et al. (1996) Generalized atrophic benign epidermolysis bullosa. Arch Dermatol 132:145–150
Kon A, Nomura K, Pulkkinen L et al. (1997) Novel glycine substitution mutations in COL7A1 reveal that the Pasini and Cockayne-Touraine variants of dominant dystrophic epidermolysis bullosa are allelic. J Invest Dermatol 109:684–687
Lin AN, Carter DM (1992) Epidermolysis bullosa: basic and clinical aspects. Springer, Berlin
Nielsen PG, Sjuland E (1985) Epidermolysis bullosa simplex localisata associated with anodontia, hair and nail disorders. Acta Derm Venereol (Stockh) 65:526–530
Olaisen B, Gedde-Dahl T (1973) GPT-epidermolysis bullosa simplex (EBS Ogna) linkage in man. Hum Hered 23: 189–196
Pasini A (1928) Dystrophie cutanée bulleuse atrophiante et al. bo-papuloide. Ann Dermatol Syph (Paris) 9:1044–1066
Reed WB, College J, Francis MJO et al. (1974) Epidermolysis bullosa dystrophica with epidermal neoplasms. Arch Dermatol 110:894–902
Ridley CM (1977) Epidermolysis bullosa with unusual features: inversa type. Pro R Soc Med 70:576–577
Ruiz-Maldonado R, Duran-McKinster C, Carrasco-Daza D et al. (1998) Intrauterine epidermal necrosis: report of three cases. J Am Acad Dermatol 38:712–715
Salih MA, Lake BD, el Hag MA et al. (1985) Lethal epidermo-lytic epidermolysis bullosa: a new autosomal recessive type of epidermolysis bullosa. Br J Dermatol 113:135–143
Shaw DW, Fine J-D, Piacquadio DJ et al. (1997) Gastric outlet obstruction and epidermolysis bullosa. J Am Acad Dermatol 36:304–310
Vailly J, Gagnoux-Palacios L, Dell’Ambra E et al. (1998) Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia. Gene Ther 5:1322–1332
Wakasugi S, Mizutari K, Ono T (1998) Clinical phenotype of Bart’s syndrome seen in a family with dominant dystrophic epidermolysis bullosa. J Dermatol 25:517–522
Pemphigus Vulgaris and Pemphigus Variants
Aberer W, Wolff-Schreiner EC, Stingl G et al. (1987) Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up. J Am Acad Dermatol 16:527–533
Ahmed RA, Blose DA (1984) Pemphigus vegetans. Neumann type and Hallopeau type. Int J Dermatol 23:135–141
Amagai M (1996) Pemphigus: autoimmunity to epidermal cell adhesion molecules. Adv Dermatol 11:319–352
Amagai M, Klaus-Kovtun V, Stanley JR (1991) Autoantibodies against a novel epithelial Cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67:869–877
Anhalt GJ, Kim SC, Stanley JR et al. (1990) Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 323:1729–1735
Asboe-Hansen G (1970) Diagnosis of pemphigus. Br J Dermatol 83: 81–92
Basset N, Guilot B, Michel B et al. (1987) Dapsone as initial treatment in superficial pemphigus. Report of nine cases. Arch Dermatol 123:783–785
Braun-Falco O, Abeck D, Meurer M (1991) Isolierter Pemphigus vulgaris der Mundschleimhaut — Pemphigustest: Diagnosesicherung mittels direkter Immunfluoreszenzuntersuchung an unbefallener Körperhaut. Hautarzt 42:623–626
Brown MV (1954) Fogo seivagem (pemphigus foliaceus). Review of the Brazilian literature. Arch Dermatol 69: 589–599
Bystryn JC, Steinman NM (1996) The adjuvant therapy of pemphigus. An update. Arch Dermatol 132:203–212
Bystryn JC, Abel E, DeFeo C (1974) Pemphigus foliaceus. Subcorneal intercellular antibodies of unique specificity. Arch Dermatol 110:857–861
Diaz LA, Sampaio SAP, Rivitti EA et al. (1989) Endemic pemphigus foliaceus (Fogo Selvagem): II. Current and historic epidemiologic studies. J Invest Dermatol 92:4–12
Fine J-D (1995) Management of acquired bullous skin diseases. N Engl J Med 333:1475–1484
Grundmann-Kollmann M, Körting HC, Behrens S et al. (1999) Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases. J Am Acad Dermatol 40:957–960
Harman KE, Black MM (1999) High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases. Br J Dermatol 140:865–874
Hashimoto T, Kiyokawa C, Mori O et al. (1997) Human des-mocollin (Dsc1) is an autoantigen for the subcorneal pustular dermatosis type of IgA pemphigus. J Invest Dermatol 109:127–131
Hodak E, David M, Ingber A et al. (1990) The clinical and histopathological spectrum of IgA-pemphigus — report of two cases. Clin Exp Dermatol 15:433–437
Huff JC, Golitz LE, Kunke KS (1985) Intraepidermal neutrophilic IgA dermatosis. N Engl J Med 313:1643–1645
Ishii K, Amagai M, Komai A et al. (1999) Desmoglein 1 and desmoglein 3 are the target autoantigens in herpetiform pemphigus. Arch Dermatol 135:943–947
Jablonska S, Chorzelski T, Beutner EH et al. (1975) Herpetiform pemphigus, a variable pattern of pemphigus. Int J Dermatol 14:353–359
Jansen T, Plewig G, Anhalt GJ (1995) Paraneoplastic pemphigus with clinical features of erosive lichen planus associated with Castleman’s tumor. Dermatology 190:245–250
Korman NJ (1990) Pemphigus. Dermatol Clin 8:689–700
Lever WF (1953) Pemphigus. Medicine 32:1–123
Lever WF (1979) Pemphigus and pemphigoid. J Am Acad Dermatol 1: 2–31
Lever WF, Schaumburg-Lever G (1984) Treatment of pemphigus vulgaris. Results obtained in 84 patients between 1961 and 1982. Arch Dermatol 120:44–47
Messer G, Sizmann N, Feucht H et al. (1995) High-dose intravenous immunoglobulins for immediate control of severe pemphigus patients. Br J Dermatol 133:1014–1016
Nishikawa T (1999) Desmoglein ELISAs. Arch Dermatol 135: 195–196
Nousari HC, Detering R, Wojtczack H et al. (1999) The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med 340:1406–1410
Ongenae KC, Temmermann LJ, Vermander F et al. (1999) Intercellular IgA dermatosis. Eur J Dermatol 9: 85–94
Robinson ND, Hashimoto T, Amagai M et al. (1999) The new pemphigus variants. J Am Acad Dermatol 40: 649–671
Senear FE, Usher B (1926) An unusual type of pemphigus combining features of lupus erythematosus. Arch Dermatol Syph 13:761–781
Stanley JR (1989) Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases. J Clin Invest 83:1443–1448
Stanley JR (1999) Therapy of pemphigus vulgaris. Arch Dermatol 135:76–78
Vieiera JP (1940) Nova contribucões ao estudo de pênfigo foliáceo (fogo-selvagem) no Estado de São Paulo. Emprésa Gráfica da „Revistas dos Tribunais
Wallach D (1986) Intraepidermal neutrophilic IgA dermatosis. N Engl J Med 315:66–67
Wallach D, Foldes C, Cotenot F (1982) Pustulose sous-cornée, acantholyse superficielle et IgA monoclonale. Ann Dermatol Venereol (Paris) 109:959–963
Wolff H,Kunte C, Messer G et al. (1999) Paraneoplastic pemphigus with fatal pulmonary involvement in a woman with a mesenteric Castleman tumour. Br J Dermatol 140: 313–316
Bullous Pemphigoid
Ahmed AR, Maize JC, Provost TT (1977) Bullous pemphigoid. Clinical and immunologic follow-up after successful therapy. Arch Dermatol 113:1043–1046
Bean SF, Michel B, Furey N et al. (1976) Vesicular pemphigoid. Arch Dermatol 113:1402–1404
Chan LS, Fine J-D, Briggaman RA et al. (1993) Identification and partial characterization of a novel 105-kD lower lamina lucida autoantigen associated with a novel immune-mediated subepidermal blistering disease. J Invest Dermatol 101:262–267
Eberhartinger C, Niebauer G (1961) Zur prognose und Therapie des Pemphis vulgaris und ähnlicher Erkrankungen. Hautarzt 12:503–508
Fox B, Odems RB, Findlay RF (1982) Erythromycin therapy in bullous pemphigoid: possible anti-inflammatory effects. J Am Acad Dermatol 7:504–510
Gohestani RF, Nicolas JF, Rousselle P et al. (1997) Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses. Arch Dermatol 133:1102–1107
Jablonska S, Chorzelski TP, Blasczyk M et al. (1984) Bullous diseases and malignancy. Semin Dermatol 3:316–326
Jung M, Kippes W, Messer G et al. (1999) Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence. J Am Acad Dermatol 41:266–268
Korman NJ (1998) Bullous pemphigoid. The latest in diagnosis, prognosis, and therapy. Arch Dermatol 134:1137–1141
Lever WF (1979) Pemphigus and pemphigoid. J Am Acad Dermatol 1:2–31
Levine N, Freilich A, Barland P (1979) Localized pemphigoid simulating dyshidrosiform dermatitis. Arch Dermatol 115:320–321
Liu HN-H, Su DWP, Rogers RS III (1986) Clinical variants of pemphigoid. Int J Dermatol 25:17–27
Nunzi E, Rongioletti F, Parodi A et al. (1988) Dyshidrosiform pemphigoid. J Am Acad Dermatol 19:568–569
Person JR, Rogers RS III (1977) Bullous pemphigoid responding to sulfapyridine and the sulfones. Arch Dermatol 113: 610–615
Person JR, Rogers RS III, Perry HO (1976) Localized pemphigoid. Br J Dermatol 95:531–534
Provost TT, Maize JC, Ahmed AR et al. (1979) Unusual subepidermal bullous disease with immunologic features of bullous pemphigoid. Arch Dermatol 115:156–160
Sato M, Shimizu H, Ishiko A et al. (1998) Precise ultrastructural localization of in vivo deposited IgG antibodies in fresh perilesional skin of patients with bullous pemphigoid. Br J Dermatol 138:593–601
Schmidt E, Obek K, Bröcker E-B et al. (2000) Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 136:174–178
Schnyder MMU (1969) Pemphigoide séborrhéique. Entité nosologique nouvelle? Bull Soc Fr Dermatol Syphiligr 76:320
Stone SP, Schroeter AL (1975) Bullous pemphigoid and associated malignant neoplasms. Arch Dermatol 111:991–994
Winkelmann RK, Su WPD (1979) Pemphigoid vegetans. Arch Dermatol 115:446–448
Yung CW, Soltani K, Lorincz AL (1981) Pemphigoid nodularis. J Am Acad Dermatol 5:54–60
Zillikens D, Kawahara Y, Ishiko A et al. (1996) A novel subepidermal blistering disease with autoantibodies against a 200-kDa antigen of the basement membrane zone. J Invest Dermatol 106:465–470
Zillikens D, Mascaro JM, Rose PA et al. (1997) A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BPi8o autoantibodies in patients with bullous pemphigoid. J Invest Dermatol 109: 679–683
Herpes Gestationis
Chimanovitch I, Schmidt E, Messer G et al. (1999) IgGi and IgG3 are the major immunoglobulin subclasses targeting epitopes within the NC16 A domain of BP180 in pemphigoid gestationis. J Invest Dermatol 113:140–142
Holmes RC, Black MM, Jurecka W et al. (1983) Clues to the aetiology and pathogenesis of herpes gestationis. Br J Dermatol 109:131–139
Jenkins RE, Hern S, Black MM (1999) Clinical features and management of 87 patients with pemphigoid gestationis. Clin Exp Dermatol 24:255–259
Morrison LH, Labib RS, Zone JJ et al. (1988) Herpes gestationis autoantibodies recognize a 180-kD human epidermal antigen. J Clin Invest 81:2023–2026
Shornick JK, Black MM (1992) Fetal risks in herpes gestationis. J Am Acad Dermatol 26:63–68
Shornick JK, Bangert JL, Freeman RG et al. (1983) Herpes gestationis: clinical and histological features of 28 cases. J Am Acad Dermatol 8:214–224
Vaughan Jones SA, Black MM (1999) Pregnancy dermatoses. J Am Acad Dermatol 40:233–241
Cicatricial Pemphigoid
Ahmed AR, Kurgis BS, Rogers RS III (1991) Cicatricial pemphigoid. J Am Acad Dermatol 24:987–1001
Balding SD, Prost C, Diaz LA et al. (1996) Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol 106: 141–146
Brunsting LA, Perry HO (1957) Benign pemphigoid? A report of seven cases with chronic, scarring herpetiform plaques about the head and neck. Arch Dermatol 75:489–501
Chan LS, Majmudar AA, Tran HH et al. (1997) Laminin-6 and Laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid. J Invest Dermatol 108:848–853
Kirtschig G, Caux F, McMillan JR et al. (1998) Acquired junctional epidermolysis bullosa associated with IgG autoantibodies to the α subunit of laminin-5. Br J Dermatol 138:125–130
Lever WF (1942) Pemphigus conjunctivae with scarring of the skin. Arch Dermatol Syph 46:875–880
Michel B, Bean SF, Chorzelski T et al. (1977) Cicatricial pemphigoid of Brunsting-Perry. Arch Dermatol 113: 1403–1405
Pandya AG, Warren KJ, Bergstresser PR (1997) Cicatricial pemphigoid successfully treated with pulse intravenous cyclophosphamide. Arch Dermatol 133:245–247
Rogers RS III, Seehafer JR, Perry HO (1982) Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone. J Am Acad Dermatol 6:215–223
Wolff K, Rappersberger K, Steiner A et al. (1987) Vegetating cicatricial pemphigoid. A new subset of the cicatricial pemphigoid spectrum. Arch Dermatol Res 279 S: 20–37
Linear IgA Dermatosis
Bhogal B, Wjnarowska F, Marsden RA et al. (1987) Linear IgA bullous dermatosis of adults and children: an im-munoelectron microscopic study. Br J Dermatol 117: 289–296
Chorzelski TP, Jablonska S (1979) IgA linear dermatosis of childhood (chronic bullous disease of childhood). Br J Dermatol 101:535–542
Collier P, Wojnarowska F, Allen J et al. (1994) Molecular overlap of the IgA target antigens in the subepidermal blistering diseases. Dermatology 189 S: 105–107
Kárpáti S, Stolz W, Meurer M et al. (1992) Ultrastructural immunogold studies in two cases of linear IgA dermatosis. Are there two distinct types of this disease? Br J Dermatol 127:112–118
Mobacken H, Kastrup W, Ljunghall K et al. (1983) Linear IgA dermatosis. A study of ten adult patients. Acta Derm Venereol (Stockh) 63:123–128
Pas HH, Kloosterhuis GJ, Heeren K et al. (1997) Bullous pemphigoid and linear IgA dermatosis sera recognize a similar 120-kDa keratinocyte collagenous glycoprotein with antigenic cross-reactivity to BP180. J Invest Dermatol 108:423–429
Pulimood S, Ajithkumar K, Jacob M et al. (1997) Linear IgA bullous dermatosis of childhood: treatment with dapsone and co-trimoxazole. Clin Exp Dermatol 22:90–91
Zambruno G, Manca V, Kanitakis J et al. (1994) Linear IgA bullous dermatosis with autoantibodies to a 290 kd antigen of anchoring fibrils. J Am Acad Dermatol 31:884–888
Epidermolysis Bullosa Acquisita
Callot-Mellot C, Bodemer C, Caux F et al. (1997) Epidermolysis bullosa acquisita in childhood. Arch Dermatol 133:1122–1126
Gammon WR, Briggaman RA, Woodley DT et al. (1984) Epidermolysis bullosa acquisita — a pemphigoid-like disease. J Am Acad Dermatol 11:820–832
Kotier H, Wambacher-Gasser B, Topar G et al. (1996) Intravenous immunoglobulin treatment in therapy-resistant epidermolysis bullosa acquisita. J Am Acad Dermatol 34:331–334
Kurzhals G, Stolz W, Meurer M et al. (1991) Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid. Arch Dermatol 127:391–395
Megahed M, Scharffetter-Kochanek K (1993) Epidermolysis bullosa acquisita — successful treatment with colchicine. Arch Dermatol Res 286:35–40
Roenigk HH Jr, Ryan JG, Bergfeld WF (1971) Epidermolysis bullosa acquisita. Report of three cases and review of all published cases. Arch Dermatol 103:1–10
Zhu XJ, Niimi Y, Bystryn JC (1990) Epidermolysis bullosa acquisita. Incidence in patients with basement membrane zone antibodies. Arch Dermatol 126:171–174
Dermatitis Herpetiformis
Cottini GB (1955) Dermatite herpétiforme de Duhring symétrique et localisée aux genoux et aux coudes. Ann Dermatol Syph 82:285–286
Crabtree JE, O’Mahony S, Wyatt JI et al. (1992) Helicobacter pylori serology in patients with coeliac disease and dermatitis herpetiformis. J Clin Pathol 45:597–600
Dieterich W, Laag E, Bruckner-Tuderman L et al. (1999) Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol 113:133–136
Duhring LA (1884) Dermatitis herpetiformis. JAMA 3:225–229
Ermacora E, Prampolini L, Tribbia G (1986) Long-term follow-up of dermatitis herpetiformis in children. J Am Acad Dermatol 15:24–29
Floden CH, Gentele H (1955) A case of clinically typical dermatitis herpetiformis presenting acantholysis. Acta Derm Venereol 35:128–131
Hardman CM, Garioch JJ, Leonard JN et al. (1997) Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med 337:1884–1887
Katz SI, Strober W (1978) The pathogenesis of dermatitis herpetiformis. J Invest Dermatol 70:63–75
Rhodes LE, Tingle MD, Park BK et al. (1995) Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy. Br J Dermatol 132: 257–262
Lichen Planus Pemphigoides
Bouloc A, Vignon-Pennamen MD, Caux F et al. (1998) Lichen planus pemphigoides is a heterogeneous disease: a report of five cases studied by immunoelectron microscopy. Br J Dermatol 138:972–980
Schreiner K (1930) Lichen ruber pemphigoides und lichen ruber vesiculosus. Arch Dermatol Syph 161:647–657
Zillikens D, Caux F, Mascaro JM et al. (1999) Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16 A domain of BP180. J Invest Dermatol 113:117–121
Bullous Diseases in Childhood
Bean SF, Good RA, Windhorst DB (1970) Bullous pemphigoid in an 11-year-old boy. Arch Dermatol 102: 205–208
Bhogal B, Wojnarowska F, Marsden RA et al. (1987) Linear IgA bullous dermatosis of adults and children. Br J Dermatol 117:289–296
Chorzelski TP, Jablonska S (1979) IgA linear dermatosis of childhood (chronic bullous disease of childhood). Br J Dermatol 101:535–542
Faber WR, Joost TH van (1973) Juvenile pemphigoid. Br J Dermatol 89:519–522
Gianotti F, Ermacora E, Prampolini L et al. (1986) Dermatitis herpetiformis in childhood. Long-term follow-up of dermatitis herpetiformis in children. J Am Acad Dermatol 15:24–30
Marsden RA (1982) The treatment of benign chronic bullous dermatosis of childhood, and dermatitis herpetiformis and bullous pemphigoid beginning in childhood. Clin Exp Dermatol 7:653–663
Marsden RA, McKee PH, Bhogal B et al. (1980) A study of benign chronic bullous dermatosis of childhood and comparison with dermatitis herpetiformis and bullous pemphigoid. Clin Exp Dermatol 5:159–176
Nemeth AJ, Klein AD, Gould EW et al. (1991) Childhood bullous pemphigoid. Clinical and immunologic features, treatment, and prognosis. Arch Dermatol 127:378–386
Rosenbaum MM, Esterly NB, Greenwald MJ et al. (1984) Cicatricial pemphigoid in a 6-year-old child: report of a case and review of the literature. Pediatr Dermatol 2:13–22
Schiffner JH (1982) Therapy of childhood linear IgA dermatitis herpetiformis. J Am Acad Dermatol 6:403–404
Surbrugg SK, Weston WL (1985) The course of chronic bullous disease of childhood. Pediatr Dermatol 2:213–215
Trueb RM, Didierjean L, Fellas A et al. (1999) Childhood bullous pemphigoid: report of a case with characterization of the targeted antigens. J Am Acad Dermatol 40:338–344
Wojnarowska F, Marsden RA, Bhogal B et al. (1988) Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. J Am Acad Dermatol 19: 792–805
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Braun-Falco, O., Plewig, G., Wolff, H.H., Burgdorf, W.H.C. (2000). Blistering Diseases. In: Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97931-6_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-97931-6_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-97933-0
Online ISBN: 978-3-642-97931-6
eBook Packages: Springer Book Archive